ARWR and SRPT Related Headlines
Go Back- Arrowhead Pharmaceuticals receives $200 million from Sarepta milestone
- Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics
- Arrowhead receives $100 million milestone from Sarepta for ARO-DM1 study
- Arrowhead Pharmaceuticals Earns $100 Million Milestone from Sarepta Therapeutics
ARWR and SRPT Related Press Releases
Go Back- Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics
- Arrowhead Pharmaceuticals Earns $100 Million Milestone from Sarepta Therapeutics

